4//SEC Filing
Hsu Frank J. 4
Accession 0001209191-19-047625
CIK 0001260990other
Filed
Aug 27, 8:00 PM ET
Accepted
Aug 28, 5:48 PM ET
Size
5.9 KB
Accession
0001209191-19-047625
Insider Transaction Report
Form 4
Hsu Frank J.
Chief Medical Officer
Transactions
- Award
Stock Option
2019-08-26−150,000→ 150,000 totalExercise: $5.64Exp: 2029-08-26→ Common Stock (150,000 underlying)
Footnotes (1)
- [F1]One-fourth (1/4th) of the shares subject to the stock options shall vest on first anniversary of the date of grant, and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments over the three-year period thereafter, subject to the Reporting Person's continued employment or service with the Issuer on each such date.
Documents
Issuer
Oncternal Therapeutics, Inc.
CIK 0001260990
Entity typeother
Related Parties
1- filerCIK 0001786723
Filing Metadata
- Form type
- 4
- Filed
- Aug 27, 8:00 PM ET
- Accepted
- Aug 28, 5:48 PM ET
- Size
- 5.9 KB